Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00279981 · ClinicalTrials.gov registry record

TRENDS: A Prospective Study of the Clinical Significance of Atrial Arrhythmias Detected by Implanted Device Diagnostics

A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

Completed
Registry status
3,100
Enrollment target

NCT00279981 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 3,100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00279981 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

COMPLETED
Registry status
3,100 participants
Enrollment target

Study Summary

The purpose of this study is to look at the heart rate and rhythm information collected daily in Medtronic implantable pulse generators (IPG), implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy (CRT) devices. The study will gather this information from many patients to see if heart rate or rhythm data can predict the risk of a patient having a medical condition such as stroke.

Interventions

  • DEVICE Diagnostic

Trial Details

FieldValue
Enrollment Target 3,100 participants
Start Date 2003-11
Est. Completion 2007-06

What the Registry Record Tells You About NCT00279981

The ClinicalTrials.gov registry entry for NCT00279981 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Diagnostic is the first listed.

NCT00279981 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00279981 about?

NCT00279981 is a clinical study titled "TRENDS: A Prospective Study of the Clinical Significance of Atrial Arrhythmias Detected by Implanted Device Diagnostics". The purpose of this study is to look at the heart rate and rhythm information collected daily in Medtronic implantable pulse generators (IPG), implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy (CRT) devices. The study will gather this information from many patients ...

What is the current status of trial NCT00279981?

This trial is currently completed. The enrollment target is 3,100 participants. The study started on 2003-11. Estimated completion is 2007-06.

What interventions are being tested in trial NCT00279981?

The interventions under investigation include: Diagnostic (DEVICE).

Who is sponsoring clinical trial NCT00279981?

This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.